At InnoGI Technologies, we lead the way in sustainable oral drug and nutritional research by advancing gastrointestinal (GI) modeling. We provide innovative services to the pharmaceutical and food industries, specializing in GI modeling through the advanced TIM® Platform. Our dynamic in vitro models mimic the entire GI tract, delivering deep, data-driven insights into digestion, absorption, and microbiome interaction. By delivering predictive, physiologically relevant results, we help our clients and partners better understand how their products behave during digestion—reducing development risks, accelerating time to market, and supporting a future with less reliance on animal testing. With over 30 years of experience in GI modeling and a track record of 250+ scientific publications InnoGI is your reliable partner for confident decision making!
| Website | http://www.innogitechnologies.com |
| Employees | 33 (25 on RocketReach) |
| Founded | 2020 |
| Address | Thijsseweg, 11, Delft, South Holland, NL |
| Industry | Research Services |
| Keywords | Drug Delivery, Gastrointestinal Research, Pharmaceutical Research, Biotechnology, Preclinical Testing, In Vitro Models, Gastrointestinal, Drug Development, Life Sciences, Pharmaceutical Development, Biopharma, In Vitro Studies, Absorption, Pharmacokinetics, Bioavailability, Drug Metabolism |
Looking for a particular InnoGI Technologies employee's phone or email?
Jeroen Kiers is the CEO of InnoGI Technologies.
25 people are employed at InnoGI Technologies.
InnoGI Technologies is based in Delft, South Holland.